← Eichor
Condition: Ursodeoxycholic Acid Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Ursodeoxycholic Acid

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA
Phase 3 · 42 location(s) · Cascade Pharmaceuticals, Inc · NCT07282353Prospective Cohort of Immune Checkpoint Inhibitor-induced Hepatitis
Phase N/A · 1 location(s) · University Hospital, Montpellier · NCT06864481Fenofibrate in Primary Biliary Cholangitis: a Real World Study
Phase 3 · 1 location(s) · Xijing Hospital of Digestive Diseases · NCT06755151Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly
NA · 1 location(s) · Phenomen Pharma · NCT07068191Perioperative Ursodeoxycholic Acid for Renal Protection in Adults Undergoing Partial Nephrectomy for Renal Tumors
Phase 2 · 1 location(s) · Jinling Hospital, China · NCT07672860Ursodeoxycholic Acid Attenuates Statin-Induced Impaired Glucose Tolerance
NA · 2 location(s) · First Affiliated Hospital Xi'an Jiaotong University · NCT06684106Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World Study
Phase 3 · 1 location(s) · Xijing Hospital of Digestive Diseases · NCT06755541Efficacy and Safety of Ursodeoxycholic Acid in Reversing Gastric Intestinal Metaplasia
Phase 4 · 6 location(s) · Yongquan Shi · NCT06610760Efficacy and Safety of Bezafibrate 400 mg and Bezafibrate 200 mg as Adjunctive Treatments in Patients With Primary Bilia
Phase 3 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06443606Ursodeoxycolic Acid for the Prevention of Relapsing Complications After Gallstone Acute Pancreatitis
Phase 3 · 18 location(s) · Hospital General Universitario de Alicante · NCT04924868The Efficacy of Ursodeoxycholic Acid (UDCA) as Adjuvant Therapy to Phototherapy in the Management of Neonatal Indirect H
NA · 1 location(s) · Tishreen University Hospital · NCT07110987Efficacy & Safety of Oral Adjuvants to Phototherapy in Neonatal Hyperbilirubinemia
Phase 4 · 1 location(s) · Amira Adel Fouly · NCT06517862Clinical Research of Tapering UDCA in PBC Patients With a Complete Response
Phase 4 · 1 location(s) · Peking Union Medical College Hospital · NCT04650243Ursodeoxycholic Acid (UDCA) as a Neuroprotective Adjuvant Treatment to Rhegmatogenous Retinal Detachment Surgery
Phase 3 · 2 location(s) · Hopital Foch · NCT06294847Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis
Phase 3 · 7 location(s) · Xijing Hospital of Digestive Diseases · NCT05751967sCD163 in PBC Patients - Assessment of Treatment Response
Phase N/A · 1 location(s) · University of Aarhus · NCT02931513Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis
Phase 2/Phase 3 · 12 location(s) · Xijing Hospital of Digestive Diseases · NCT05749822
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.